W. R. Tracey

发表

A novel sodium-hydrogen exchanger isoform-1 inhibitor, zoniporide, reduces ischemic myocardial injury in vitro and in vivo.

R. J. Hill, D. Flynn, D. Knight, 2001, The Journal of pharmacology and experimental therapeutics.

The Sulfonylurea Glipizide Does Not Inhibit Ischemic Preconditioning in Anesthetized Rabbits

Carolyn B Levy, W. Soeller, J. Treadway, 2005, Cardiovascular Drugs and Therapy.

Aldose reductase inhibition alone or combined with an adenosine A(3) agonist reduces ischemic myocardial injury.

P. Oates, D. Knight, A. Smith, 2000, American journal of physiology. Heart and circulatory physiology.

6 Selective activation of adenosine A receptors with N -(3-chlorobenzyl)- 3 5 9 - N -methylcarboxamidoadenosine (CB-MECA) provides cardioprotection via K channel activation ATP

R. J. Hill, J. Oleynek, H. Masamune, 1998 .

Selective activation of adenosine A3 receptors with N6-(3-chlorobenzyl)-5'-N-methylcarboxamidoadenosine (CB-MECA) provides cardioprotection via KATP channel activation.

R. J. Hill, J. Oleynek, H. Masamune, 1998, Cardiovascular research.

Selective adenosine A3 receptor stimulation reduces ischemic myocardial injury in the rabbit heart.

R. J. Hill, D. Knight, S. Kennedy, 1997, Cardiovascular research.

Evidence for a role for both the adenosine A1 and A3 receptors in protection of isolated human atrial muscle against simulated ischaemia.

R. J. Hill, D. Knight, D. Yellon, 1997, Cardiovascular research.

Cloning, expression and pharmacological characterization of rabbit adenosine A1 and A3 receptors.

R. J. Hill, D. Knight, J. Oleynek, 1997, The Journal of pharmacology and experimental therapeutics.

Expression of inducible nitric oxide synthase in failing and non-failing human heart.

U. Förstermann, A. Nüssler, H. Scholz, 1996, Journal of molecular and cellular cardiology.

Novel N6-substituted adenosine 5'-N-methyluronamides with high selectivity for human adenosine A3 receptors reduce ischemic myocardial injury.

R. J. Hill, D. Flynn, D. Knight, 2003, American journal of physiology. Heart and circulatory physiology.

Immunochemical detection of inducible NO synthase in human lung.

R. Johns, J. Pollock, U. Förstermann, 1994, The American journal of physiology.

Isoforms of nitric oxide synthase: functions in the cardiovascular system.

M. Nakane, J. Pollock, U. Förstermann, 1993, European heart journal.

Zoniporide: a potent and selective inhibitor of the human sodium-hydrogen exchanger isoform 1 (NHE-1).

A. Fossa, D. Knight, A. Guzman-Perez, 2006, Cardiovascular drug reviews.

Differing cardioprotective efficacy of the Na+/Ca2+ exchanger inhibitors SEA0400 and KB-R7943.

J. Chapman, G. Deshmukh, M. Deninno, 2003, American journal of physiology. Heart and circulatory physiology.

A novel nonpeptidic caspase-3/7 inhibitor, (S)-(+)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin reduces myocardial ischemic injury.

A. Milici, J. Chapman, H. Stukenbrok, 2002, European journal of pharmacology.

Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors.

G. Carter, W. R. Tracey, J. Tse, 1995, The Journal of pharmacology and experimental therapeutics.

Responses of isolated guinea pig pulmonary venules to hypoxia and anoxia.

N. Paterson, W. R. Tracey, J. T. Hamilton, 1989, Journal of applied physiology.

Cloning , Expression and Pharmacological Characterization of Rabbit Adenosine A 1 and A 3 Receptors

R. J. Hill, D. Knight, J. Oleynek, 1997 .

The A3 Adenosine Receptor Agonist CP-532,903 [N6-(2,5-Dichlorobenzyl)-3′-aminoadenosine-5′-N-methylcarboxamide] Protects against Myocardial Ischemia/Reperfusion Injury via the Sarcolemmal ATP-Sensitive Potassium Channel

G. Gross, M. Bienengraeber, Z. Ge, 2008, Journal of Pharmacology and Experimental Therapeutics.

Relative importance of adenosine A1 and A3 receptors in mediating physiological or pharmacological protection from ischemic myocardial injury in the rabbit heart.

R. J. Hill, D. Knight, J. Oleynek, 1998, Journal of molecular and cellular cardiology.

Discovery of zoniporide: a potent and selective sodium-hydrogen exchanger type 1 (NHE-1) inhibitor with high aqueous solubility.

R. J. Hill, D. Knight, A. Guzman-Perez, 2001, Bioorganic & medicinal chemistry letters.

59-N-methylcarboxamidoadenosine (CB-MECA) provides cardioprotection via K channel activation

R. J. Hill, J. Oleynek, H. Masamune, 1998 .

Comparison of spectrophotometric and biological assays for nitric oxide (NO) and endothelium-derived relaxing factor (EDRF): nonspecificity of the diazotization reaction for NO and failure to detect EDRF.

R. Johns, M. Peach, J. Linden, 1990, The Journal of pharmacology and experimental therapeutics.

Differential muscarinic receptor mRNA expression by freshly isolated and cultured bovine aortic endothelial cells.

M. Peach, W. R. Tracey, 1992, Circulation research.

Cardioprotective efficacy of zoniporide, a potent and selective inhibitor of Na+/H+ exchanger isoform 1, in an experimental model of cardiopulmonary bypass

M. Avkiran, M. Allen, W. R. Tracey, 2004, British journal of pharmacology.

Isoforms of nitric-oxide synthase: purification and regulation.

M. Nakane, J. Pollock, U. Förstermann, 1994, Methods in enzymology.

In vivo pharmacological evaluation of two novel type II (inducible) nitric oxide synthase inhibitors.

M. Nakane, G. Carter, W. R. Tracey, 1995, Canadian journal of physiology and pharmacology.

Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease.

J. Pollock, P. Grammas, W. R. Tracey, 1994, Biochemical and biophysical research communications.

Spectrophotometric detection of nitrogen oxides using azo dyes

W. R. Tracey, 1992 .

Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels.

D. Harrison, J. Pollock, J. Wilcox, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Isozyme-nonselective N-Substituted Bipiperidylcarboxamide Acetyl-CoA Carboxylase Inhibitors Reduce Tissue Malonyl-CoA Concentrations, Inhibit Fatty Acid Synthesis, and Increase Fatty Acid Oxidation in Cultured Cells and in Experimental Animals*

D. Hargrove, D. Dalvie, J. Chapman, 2003, Journal of Biological Chemistry.

Zoniporide: a potent and highly selective inhibitor of human Na(+)/H(+) exchanger-1.

R. J. Hill, D. Knight, Janice A. Brown, 2002, European journal of pharmacology.

Relationships between NADPH diaphorase staining and neuronal, endothelial, and inducible nitric oxide synthase and cytochrome P450 reductase immunoreactivities in guinea-pig tissues

H. Young, B. Masters, J. Furness, 1997, Histochemistry and Cell Biology.

Identification of an endothelial-like type III NO synthase in LLC-PK1 kidney epithelial cells.

F. Murad, M. Nakane, J. Pollock, 1994, The American journal of physiology.

Effect of endothelial injury on the responses of isolated guinea pig pulmonary venules to reduced oxygen tension.

N. Paterson, W. R. Tracey, J. T. Hamilton, 1989, The American review of respiratory disease.

Nitric oxide synthase isozymes antibodies

M. Nakane, J. Pollock, U. Förstermann, 1995, The Histochemical Journal.

Nitric oxide synthase isozymes antibodies

M. Nakane, J. Pollock, U. Förstermann, 2004, The Histochemical Journal.

Cardioprotective effects of ingliforib, a novel glycogen phosphorylase inhibitor.

Carolyn B Levy, R. McPherson, J. Treadway, 2004, American journal of physiology. Heart and circulatory physiology.

Nitric oxide synthases in neuronal cells, macrophages and endothelium are NADPH diaphorases, but represent only a fraction of total cellular NADPH diaphorase activity.

M. Nakane, J. Pollock, U. Förstermann, 1993, Biochemical and biophysical research communications.

The synthesis of highly potent, selective, and water-soluble agonists at the human adenosine A3 receptor.

R. J. Hill, D. Knight, J. Oleynek, 2006, Bioorganic & medicinal chemistry letters.

3'-Aminoadenosine-5'-uronamides: discovery of the first highly selective agonist at the human adenosine A3 receptor.

R. J. Hill, D. Knight, J. Oleynek, 2003, Journal of medicinal chemistry.

The nitric oxide synthase inhibitor, L-NG-monomethylarginine, reduces carrageenan-induced pleurisy in the rat.

M. Nakane, J. Kuk, G. Carter, 1995, The Journal of pharmacology and experimental therapeutics.

Effects of bradykinin and leukotrienes B4 and D4 on the bovine brochial arteryin vitro: Role of the endothelium

P. Eyre, W. R. Tracey, 1988, Agents and Actions.

Role of lipoxygenase, cyclooxygenase and cytochrome P-450 metabolites in contractions of isolated guinea pig pulmonary venules induced by hypoxia and anoxia.

N. Paterson, J. Bend, W. R. Tracey, 1989, The Journal of pharmacology and experimental therapeutics.